REPORTS

Let’s Pullulate and Expand Your Business

Intrauterine Contraceptive Devices Market - Global Professional Analysis and Forecast to 2026

Oct 09, 2019  |  160 PAGES  |  REPORT CODE: CMM202369
  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • INDUSTRY COVERAGE

The worldwide Intrauterine Contraceptive Devices market was valued at XX.0 Million US$ in 2018 and is projected to reach XX.0 Million US$ by 2026, at a CAGR (Compound Annual Growth Rate) of 7.2% during the forecast period.

This report presents the market size and development trends by detailing the Intrauterine Contraceptive Devices market revenue, market share and growth rate from 2015-2026, and it gives a thorough analysis by various product types, applications, regions, and main participants. The market conditions (2015-2019), corporate competition pattern, corporate SWOT analysis are elaborated, and other qualitative analyses like market dynamics, market penetration, market business environment analyses, the regional regulatory scenario in the Intrauterine Contraceptive Devices market will be shown in this report. In short, this report will comprehensively reveal the characteristics of Intrauterine Contraceptive Devices industry and will help you to build a panoramic view of the industrial development.

Intrauterine Contraceptive Devices Market, By Type:

  • Hormonal Intra uterine device

  • Copper Intra uterine device

Intrauterine Contraceptive Devices Market, By Application:

  • Hospitals

  • Gynecology clinics

  • Others

Some of the leading players are as follows:

  • Church & Dwight, Co. Inc.

  • Agile Therapeutics

  • Johnson & Johnson, Ltd

  • Actavis PLC

  • Pfizer

  • The Female Health Company

  • Mylan Laboratories

  • Teva Pharmaceuticals, Ltd.

  • Fuji Latex Co., Ltd

  • Reckitt Benckiser Group, PLC

  • Okamato Industries, Inc.

  • Merck & Co.

  • Bayer Healthcare

  • ANI Pharmaceuticals, Inc.

  • Lupin Pharmaceuticals, Ltd

Geographically, Major regions are analyzed in details are as follows:

  • North America

  • Europe

  • Asia Pacific

  • Latin America

  • Middle East & Africa

Table of Contents

1 Methodology and Scope

  • 1.1 Market Segmentation & Scope

    • 1.1.1 Technology Type

    • 1.1.2 Product

    • 1.1.3 Application

    • 1.1.4 Regional scope

    • 1.1.5 Estimates and forecast timeline

  • 1.2 Research Methodology

  • 1.3 Information Procurement

    • 1.3.1 Purchased database

    • 1.3.2 Internal database

    • 1.3.3 Secondary sources

    • 1.3.4 Primary research

    • 1.3.5 Details of primary research

  • 1.4 Information or Data Analysis

    • 1.4.1 Data analysis models

  • 1.5 Market Formulation & Validation

  • 1.6 Model Details

    • 1.6.1 Commodity flow analysis

    • 1.6.2 Volume price analysis

  • 1.7 List of Secondary Sources

  • 1.8 List of Abbreviations

2 Executive Summary

  • 2.1 Market Outlook

  • 2.2 Segment Outlook

3 Market Variables, Trends, & Scope

  • 3.1 Market Lineage Outlook

  • 3.1.1 Parent market outlook

    • 3.1.2 Ancillary market outlook

  • 3.2 Market Segmentation

    • 3.2.1 Analysis

  • 3.3 Market Dynamics

    • 3.3.1 Market driver analysis

    • 3.3.2 Market restraint analysis

    • 3.3.3 Industry opportunities

  • 3.4 Penetration & Growth Prospect Mapping

    • 3.4.1 Penetration & growth prospect mapping analysis

  • 3.5 Business Environment Analysis Tools

    • 3.5.1 Porter's five forces analysis

    • 3.5.2 PESTLE analysis

    • 3.5.3 Major deals & strategic alliances analysis

4 Intrauterine Contraceptive Devices Market: Technology Type Analysis

  • 4.1 Intrauterine Contraceptive Devices Technology Type Market Share Analysis, 2018 & 2026

  • 4.2 Intrauterine Contraceptive Devices Technology Type Market: Segment Dashboard

  • 4.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Technology Type Segment

    • 4.3.1 Hormonal Intra uterine device

    • 4.3.2 Copper Intra uterine device

5 Intrauterine Contraceptive Devices Market: Product Analysis

  • 5.1 Intrauterine Contraceptive Devices Product Market Share Analysis, 2018 & 2026

  • 5.2 Intrauterine Contraceptive Devices Product Market: Segment Dashboard

  • 5.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Product Segment

6 Intrauterine Contraceptive Devices Market: Application Analysis

  • 6.1 Intrauterine Contraceptive Devices Application Market Share Analysis, 2018 & 2026

  • 6.2 Intrauterine Contraceptive Devices Application Market: Segment Dashboard

  • 6.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Application Segment

    • 6.3.1 Hospitals

    • 6.3.2 Gynecology clinics

    • 6.3.3 Others

7 Intrauterine Contraceptive Devices Market: Regional Analysis

  • 7.1 Intrauterine Contraceptive Devices Regional Market Share Analysis, 2018 & 2026

  • 7.2 Intrauterine Contraceptive Devices Regional Market: Segment Dashboard

  • 7.3 Regional Market Snapshot (Market Size, CAGR, Top Countries)

  • 7.4 List of Players at Regional Level

    • 7.4.1 North America

    • 7.4.2 Europe

    • 7.4.3 Asia Pacific

  • 7.5 SWOT Analysis, by Factor (Political & Legal, Economic and Technological)

    • 7.5.1 North America

    • 7.5.2 Europe

    • 7.5.3 Asia Pacific

    • 7.5.4 Latin America

    • 7.5.5 MEA

  • 7.6 Market Size & Forecasts, and Trend Analysis, 2015 to 2026

    • 7.6.1 North America

    • 7.6.2 Europe

    • 7.6.3 Asia Pacific

    • 7.6.4 Latin America

    • 7.6.5 Middle East & Africa

8 Competitive Analysis

  • 8.1 Recent Developments & Impact Analysis, by Key Market Participants

  • 8.2 Strategic Framework/Competition Categorization (Key innovators, Market leaders, Emerging players)

  • 8.3 Vendor Landscape

    • 8.3.1 Company market position analysis (Geographic presence, service portfolio, strategic initiatives)

9 Company Profiles

  • 9.1 Church & Dwight, Co. Inc.

    • 9.1.1 Church & Dwight, Co. Inc. Company overview

    • 9.1.2 Financial performance

    • 9.1.3 Product benchmarking

    • 9.1.4 Strategic initiatives

    • 9.1.5 SWOT analysis

  • 9.2 Agile Therapeutics

    • 9.2.1 Agile Therapeutics Company overview

    • 9.2.2 Financial performance

    • 9.2.3 Product benchmarking

    • 9.2.4 Strategic initiatives

    • 9.2.5 SWOT analysis

  • 9.3 Johnson & Johnson, Ltd

    • 9.3.1 Johnson & Johnson, Ltd Company overview

    • 9.3.2 Financial performance

    • 9.3.3 Product benchmarking

    • 9.3.4 Strategic initiatives

    • 9.3.5 SWOT analysis

  • 9.4 Actavis PLC

    • 9.4.1 Actavis PLC Company overview

    • 9.4.2 Financial performance

    • 9.4.3 Product benchmarking

    • 9.4.4 Strategic initiatives

    • 9.4.5 SWOT analysis

  • 9.5 Pfizer

    • 9.5.1 Pfizer Company overview

    • 9.5.2 Financial performance

    • 9.5.3 Product benchmarking

    • 9.5.4 Strategic initiatives

    • 9.5.5 SWOT analysis

  • 9.6 The Female Health Company

    • 9.6.1 The Female Health Company Company overview

    • 9.6.2 Financial performance

    • 9.6.3 Product benchmarking

    • 9.6.4 Strategic initiatives

    • 9.6.5 SWOT analysis

  • 9.7 Mylan Laboratories

    • 9.7.1 Mylan Laboratories Company overview

    • 9.7.2 Financial performance

    • 9.7.3 Product benchmarking

    • 9.7.4 Strategic initiatives

    • 9.7.5 SWOT analysis

  • 9.8 Teva Pharmaceuticals, Ltd.

    • 9.8.1 Teva Pharmaceuticals, Ltd. Company overview

    • 9.8.2 Financial performance

    • 9.8.3 Product benchmarking

    • 9.8.4 Strategic initiatives

    • 9.8.5 SWOT analysis

  • 9.9 Fuji Latex Co., Ltd

    • 9.9.1 Fuji Latex Co., Ltd Company overview

    • 9.9.2 Financial performance

    • 9.9.3 Product benchmarking

    • 9.9.4 Strategic initiatives

    • 9.9.5 SWOT analysis

  • 9.10 Reckitt Benckiser Group, PLC

    • 9.10.1 Reckitt Benckiser Group, PLC Company overview

    • 9.10.2 Financial performance

    • 9.10.3 Product benchmarking

    • 9.10.4 Strategic initiatives

    • 9.10.5 SWOT analysis

  • 9.11 Okamato Industries, Inc.

    • 9.11.1 Okamato Industries, Inc. Company overview

    • 9.11.2 Financial performance

    • 9.11.3 Product benchmarking

    • 9.11.4 Strategic initiatives

    • 9.11.5 SWOT analysis

  • 9.12 Merck & Co.

    • 9.12.1 Merck & Co. Company overview

    • 9.12.2 Financial performance

    • 9.12.3 Product benchmarking

    • 9.12.4 Strategic initiatives

    • 9.12.5 SWOT analysis

  • 9.13 Bayer Healthcare

    • 9.13.1 Bayer Healthcare Company overview

    • 9.13.2 Financial performance

    • 9.13.3 Product benchmarking

    • 9.13.4 Strategic initiatives

    • 9.13.5 SWOT analysis

  • 9.14 ANI Pharmaceuticals, Inc.

    • 9.14.1 ANI Pharmaceuticals, Inc. Company overview

    • 9.14.2 Financial performance

    • 9.14.3 Product benchmarking

    • 9.14.4 Strategic initiatives

    • 9.14.5 SWOT analysis

  • 9.15 Lupin Pharmaceuticals, Ltd

    • 9.15.1 Lupin Pharmaceuticals, Ltd Company overview

    • 9.15.2 Financial performance

    • 9.15.3 Product benchmarking

    • 9.15.4 Strategic initiatives

    • 9.15.5 SWOT analysis

 

The List of Tables and Figures (Totals 82 Figures and 125 Tables)

  • Figure Hormonal Intra uterine device Intrauterine Contraceptive Devices market, 2015 - 2026 (USD Million)

  • Figure Copper Intra uterine device Intrauterine Contraceptive Devices market, 2015 - 2026 (USD Million)

  • Figure Hospitals market, 2015 - 2026 (USD Million)

  • Figure Gynecology clinics market, 2015 - 2026 (USD Million)

  • Figure Others market, 2015 - 2026 (USD Million)

  • Table List of players in North America

  • Table List of players in Europe

  • Table List of players in Asia Pacific

  • Table SWOT analysis

  • Table North America Intrauterine Contraceptive Devices market, by country, 2015 - 2026 (USD Million)

  • Table North America Intrauterine Contraceptive Devices market, by type, 2015 - 2026 (USD Million)

  • Table North America Intrauterine Contraceptive Devices market, by product, 2015 - 2026 (USD Million)

  • Table North America Intrauterine Contraceptive Devices market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table U.S. Intrauterine Contraceptive Devices market, by type, 2015 - 2026 (USD Million)

  • Table U.S. Intrauterine Contraceptive Devices market, by product, 2015 - 2026 (USD Million)

  • Table U.S. Intrauterine Contraceptive Devices market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Canada Intrauterine Contraceptive Devices market, by type, 2015 - 2026 (USD Million)

  • Table Canada Intrauterine Contraceptive Devices market, by product, 2015 - 2026 (USD Million)

  • Table Canada Intrauterine Contraceptive Devices market, by application, 2015 - 2026 (USD Million)

  • Table Europe Intrauterine Contraceptive Devices market, by country, 2015 - 2026 (USD Million)

  • Table Europe Intrauterine Contraceptive Devices market, by type, 2015 - 2026 (USD Million)

  • Table Europe Intrauterine Contraceptive Devices market, by product, 2015 - 2026 (USD Million)

  • Table Europe Intrauterine Contraceptive Devices market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table U.K. Intrauterine Contraceptive Devices market, by type, 2015 - 2026 (USD Million)

  • Table U.K. Intrauterine Contraceptive Devices market, by product, 2015 - 2026 (USD Million)

  • Table U.K. Intrauterine Contraceptive Devices market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Germany Intrauterine Contraceptive Devices market, by type, 2015 - 2026 (USD Million)

  • Table Germany Intrauterine Contraceptive Devices market, by product, 2015 - 2026 (USD Million)

  • Table Germany Intrauterine Contraceptive Devices market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table France Intrauterine Contraceptive Devices market, by type, 2015 - 2026 (USD Million)

  • Table France Intrauterine Contraceptive Devices market, by product, 2015 - 2026 (USD Million)

  • Table France Intrauterine Contraceptive Devices market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Italy Intrauterine Contraceptive Devices market, by type, 2015 - 2026 (USD Million)

  • Table Italy Intrauterine Contraceptive Devices market, by product, 2015 - 2026 (USD Million)

  • Table Italy Intrauterine Contraceptive Devices market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Spain Intrauterine Contraceptive Devices market, by type, 2015 - 2026 (USD Million)

  • Table Spain Intrauterine Contraceptive Devices market, by product, 2015 - 2026 (USD Million)

  • Table Spain Intrauterine Contraceptive Devices market, by application, 2015 - 2026 (USD Million)

  • Table Asia Pacific Intrauterine Contraceptive Devices market, by country, 2015 - 2026 (USD Million)

  • Table Asia Pacific Intrauterine Contraceptive Devices market, by type, 2015 - 2026 (USD Million)

  • Table Asia Pacific Intrauterine Contraceptive Devices market, by product, 2015 - 2026 (USD Million)

  • Table Asia Pacific Intrauterine Contraceptive Devices market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table China Intrauterine Contraceptive Devices market, by type, 2015 - 2026 (USD Million)

  • Table China Intrauterine Contraceptive Devices market, by product, 2015 - 2026 (USD Million)

  • Table China Intrauterine Contraceptive Devices market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Japan Intrauterine Contraceptive Devices market, by type, 2015 - 2026 (USD Million)

  • Table Japan Intrauterine Contraceptive Devices market, by product, 2015 - 2026 (USD Million)

  • Table Japan Intrauterine Contraceptive Devices market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table India Intrauterine Contraceptive Devices market, by type, 2015 - 2026 (USD Million)

  • Table India Intrauterine Contraceptive Devices market, by product, 2015 - 2026 (USD Million)

  • Table India Intrauterine Contraceptive Devices market, by application, 2015 - 2026 (USD Million)

  • Table Latin America Intrauterine Contraceptive Devices market, by country, 2015 - 2026 (USD Million)

  • Table Latin America Intrauterine Contraceptive Devices market, by type, 2015 - 2026 (USD Million)

  • Table Latin America Intrauterine Contraceptive Devices market, by product, 2015 - 2026 (USD Million)

  • Table Latin America Intrauterine Contraceptive Devices market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Brazil Intrauterine Contraceptive Devices market, by type, 2015 - 2026 (USD Million)

  • Table Brazil Intrauterine Contraceptive Devices market, by product, 2015 - 2026 (USD Million)

  • Table Brazil Intrauterine Contraceptive Devices market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Mexico Intrauterine Contraceptive Devices market, by type, 2015 - 2026 (USD Million)

  • Table Mexico Intrauterine Contraceptive Devices market, by product, 2015 - 2026 (USD Million)

  • Table Mexico Intrauterine Contraceptive Devices market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Argentina Intrauterine Contraceptive Devices market, by type, 2015 - 2026 (USD Million)

  • Table Argentina Intrauterine Contraceptive Devices market, by product, 2015 - 2026 (USD Million)

  • Table Argentina Intrauterine Contraceptive Devices market, by application, 2015 - 2026 (USD Million)

  • Table MEA Intrauterine Contraceptive Devices market, by country, 2015 - 2026 (USD Million)

  • Table MEA Intrauterine Contraceptive Devices market, by type, 2015 - 2026 (USD Million)

  • Table MEA Intrauterine Contraceptive Devices market, by product, 2015 - 2026 (USD Million)

  • Table MEA Intrauterine Contraceptive Devices market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table South Africa Intrauterine Contraceptive Devices market, by type, 2015 - 2026 (USD Million)

  • Table South Africa Intrauterine Contraceptive Devices market, by product, 2015 - 2026 (USD Million)

  • Table South Africa Intrauterine Contraceptive Devices market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Nigeria Intrauterine Contraceptive Devices market, by type, 2015 - 2026 (USD Million)

  • Table Nigeria Intrauterine Contraceptive Devices market, by product, 2015 - 2026 (USD Million)

  • Table Nigeria Intrauterine Contraceptive Devices market, by application, 2015 - 2026 (USD Million)

  • Table Recent Developments & Impact Analysis, by Key Market Participants

  • Table Recent Developments & Impact Analysis, by Key Market Participants

  • Table Company market position analysis

  • Table Company Profiles

  • Table Church & Dwight, Co. Inc. Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Agile Therapeutics Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Johnson & Johnson, Ltd Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Actavis PLC Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Pfizer Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table The Female Health Company Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Mylan Laboratories Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Teva Pharmaceuticals, Ltd. Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Fuji Latex Co., Ltd Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Reckitt Benckiser Group, PLC Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Okamato Industries, Inc. Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Merck & Co. Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Bayer Healthcare Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table ANI Pharmaceuticals, Inc. Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Lupin Pharmaceuticals, Ltd Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

Report Purchase

reports
$4840
$9680
BUY NOWClick MeBUY NOW
top